Analyst Price Targets — HNGE
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 10, 2026 3:48 pm | Jailendra Singh | Truist Financial | $112.00 | $91.66 | StreetInsider | Hinge Health Inc (HNGE) PT Raised to $112 at Truist Securities |
| August 5, 2026 12:09 pm | Elizabeth Anderson | Evercore ISI | $105.00 | $84.91 | TheFly | Hinge Health price target raised to $105 from $100 at Evercore ISI |
| August 5, 2026 11:42 am | Rishi Jaluria | RBC Capital | $110.00 | $79.42 | TheFly | Hinge Health price target raised to $110 from $75 at RBC Capital |
| August 5, 2026 11:09 am | Richard Close | Canaccord Genuity | $105.00 | $79.42 | TheFly | Hinge Health price target raised to $105 from $100 at Canaccord |
| August 5, 2026 10:07 am | David Grossman | Stifel Nicolaus | $96.00 | $79.42 | StreetInsider | Hinge Health Inc (HNGE) PT Raised to $96 at Stifel |
| August 5, 2026 9:13 am | — | Barclays | $100.00 | $79.42 | TheFly | Hinge Health price target raised to $100 from $97 at Barclays |
| July 27, 2026 10:33 am | — | Stifel Nicolaus | $90.00 | $74.31 | TheFly | Hinge Health price target raised to $90 from $79 at Stifel |
| July 21, 2026 10:52 am | — | Canaccord Genuity | $100.00 | $87.70 | TheFly | Hinge Health price target raised to $100 from $76 at Canaccord |
| July 13, 2026 10:51 am | Craig Hettenbach | Morgan Stanley | $108.00 | $88.80 | TheFly | Hinge Health price target raised to $108 from $72 at Morgan Stanley |
| July 13, 2026 10:25 am | Saket Kalia | Barclays | $97.00 | $88.80 | TheFly | Hinge Health price target raised to $97 from $70 at Barclays |
Latest News for HNGE
Hinge Health Inc. (HNGE) reported earnings 30 days ago. What's next for the stock?
Bond yields have the entire stock market on edge. The last thing most investors are thinking about is short squeezes, which means maybe they should be something contrarian trades have on their radar.
Hinge stock found support at a key level in recent weeks and is approaching multiple new buy points despite market weakness.
Many people know that seemingly unrelated symptoms can be connected. But in most cases, treating individual symptoms means a separate doctor visit, sometimes to different specialists, before the full picture emerges.
Hinge Health's nearly 90% YTD surge is backed by 53% revenue growth, wider margins and expansion into migraine and GI care, but execution risks remain.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for HNGE.
U.S. House Trading
No House trades found for HNGE.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.